Related Experiment Videos

[Selected risk factors of thrombotic complications in patients with ulcerative colitis]

Antoni Stadnicki1, Barbara Bojko, Kinga Myczkowska

  • 1Katedry i Oddziału Klinicznego Chorób Wewnetrznych w Sosnowcu.

Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|February 19, 2004
PubMed

Insights

This study found that ulcerative colitis (UC) patients have higher platelet counts and prolonged activated partial thromboplastin time (aPTT), indicating potential coagulation abnormalities. These findings suggest increased risk for thromboembolic complications in UC patients.

Area of Science:

  • Gastroenterology
  • Hematology
  • Internal Medicine

Background:

  • Ulcerative colitis (UC) is associated with an increased risk of thromboembolic events.
  • Understanding prothrombotic risk factors in UC is crucial for patient management.

Purpose of the Study:

  • To analyze prothrombotic risk factors in patients with ulcerative colitis (UC).
  • To compare these factors with control subjects having other gastrointestinal disorders.

Main Methods:

  • Analysis of 124 UC patients hospitalized between 1991 and 2000.
  • Comparison of coagulation parameters (platelets, aPTT, antithrombin, protein C, protein S) and lipid levels between UC patients and controls.
  • Assessment of smoking habits and hematocrit levels in UC patients.

Main Results:

  • UC patients exhibited significantly higher platelet levels (p < 0.001) and prolonged activated partial thromboplastin time (aPTT) (p < 0.05) compared to controls.
  • A decrease in plasma antithrombin and/or protein S was observed in approximately 22% of UC patients, with significantly lower mean protein S levels (p < 0.02).
  • While lipid levels were not significantly different, smoking showed a positive correlation with hematocrit (p < 0.05), suggesting it as a potential vascular complication risk factor in UC.

Conclusions:

  • Coagulation abnormalities, including altered platelet counts and prolonged aPTT, are potential risk factors for thromboembolic complications in UC.
  • Plasma lipid changes do not appear to be independent risk factors for vascular complications in UC.
  • Evaluating prothrombotic factors and associated ischemic heart diseases may hold prognostic value in managing UC.

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...